Blue Chip Partners, Inc. Charles River Laboratories International, Inc. Transaction History

Blue Chip Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$204.13 - $302.4 $256,387 - $379,814	-1,256 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$255.51 - $362.11 $12,519 - $17,743	49 Added 4.06%	1,256 $357,000
Q4 2021 Feb 08, 2022	BUY	$351.38 - $448.68 $152,850 - $195,175	435 Added 56.35%	1,207 $455,000
Q3 2021 Nov 02, 2021	BUY	$372.64 - $458.3 $287,678 - $353,807	772 New	772 $318,000

693

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.55B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Blue Chip Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Blue Chip Partners, Inc. with notifications on news.